tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with morphiceptin, n-me-phe(3)- in 2 studies
| Studies (tyrosyl-arginyl-phenylalanyl-lysinamide) | Trials (tyrosyl-arginyl-phenylalanyl-lysinamide) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide) | Studies (morphiceptin, n-me-phe(3)-) | Trials (morphiceptin, n-me-phe(3)-) | Recent Studies (post-2010) (morphiceptin, n-me-phe(3)-) |
|---|---|---|---|---|---|
| 74 | 0 | 17 | 95 | 1 | 1 |
| Protein | Taxonomy | tyrosyl-arginyl-phenylalanyl-lysinamide (IC50) | morphiceptin, n-me-phe(3)- (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.243 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyer, ME | 1 |
| Krylatov, AV; Lishmanov, IuB; Maslov, LN | 1 |
2 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and morphiceptin, n-me-phe(3)-
| Article | Year |
|---|---|
Behavioral effects of the mu-opioid peptide agonists DAMGO, DALDA, and PL017 on locomotor activities.
Topics: Amino Acid Sequence; Analgesics; Animals; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Injections, Intraventricular; Male; Molecular Sequence Data; Motor Activity; Oligopeptides; Rats; Receptors, Opioid; Receptors, Opioid, mu | 1993 |
[Peripheral mu-opiate receptors and regulation of cardiac resistance to arrhythmogenic effects].
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Endorphins; Male; Oligopeptides; Peptides; Rats; Rats, Wistar; Receptors, Opioid, mu | 1998 |